Dr. Mollie Monnig: Reducing Systemic and Neural Inflammation

Monnig, MolliePI: Dr. Mollie  Monnig

Probiotics to Reduce Systemic and Neural Inflammation in Heavy Drinkers

This project is a 30-day, open-label clinical trial of probiotics as an intervention to reduce systemic and neural inflammation in heavy drinkers.  The study will recruit 15 non-treatment-seeking heavy drinkers to complete the pre/post design.  Main outcomes are plasma biomarkers of immune activation and brain metabolites associated with neuroinflammation.

Component Location

ARCH Pilot Grant Program